Lexicon Pharmaceuticals, Inc. (LXRX) NASDAQ
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
Lexicon Pharmaceuticals, Inc.
Address
2445 Technology Forest Boulevard
The Woodlands, TX 77381
United States of America (the)
Phone
281 863 3000
Website
Sector
Healthcare
Industry
Biotechnology
Employees
81
First IPO Date
April 07, 2000
Key Executives
| Name | Title | Pay | Year Born |
| Michael Exton | Chief Executive Officer & Director | 1.15M | 1970 |
| Kristen L. Alexander | Vice President of Finance & Accounting | 379,807 | 1968 |
| Wendy E. McDermott | Senior Vice President of Human Resources | 580,446 | 1971 |
| Scott Coiante | Senior Vice President & Chief Financial Officer | 646,287 | 1967 |
| Brian T. Crum | Senior Vice President, General Counsel & Secretary | 687,366 | 1973 |
| Craig Granowitz | Senior Vice President & Chief Medical Officer | 789,535 | 1965 |
| Rachel Yap Martens | Senior VP of Partnerships & Corporate Strategy | 0 | 1984 |
| Suma Gopinathan | Senior Vice President of Discovery | 0 | 1973 |
| Lisa DeFrancesco | Senior Vice President of Investor Relations & Corporate Communications | 0 | 1980 |
Description
Lexicon Pharmaceuticals, Inc. is a biopharmaceutical company dedicated to the end-to-end process of identifying, advancing, and bringing to market novel therapeutic compounds. Its development pipeline includes orally administered small molecule drug candidates such as Sotagliflozin, which has successfully concluded Phase III clinical studies for treating both heart failure and type 1 diabetes, and LX9211, currently undergoing Phase II clinical development for neuropathic pain. The firm maintains important strategic collaborations and licensing arrangements with pharmaceutical industry leaders, including Bristol-Myers Squibb Company and Genentech, Inc. Established in 1995, Lexicon Pharmaceuticals, Inc. is based in The Woodlands, Texas.
